What is the pediatric Norwood procedure for hypoplastic left heart syndrome (HLHS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

The Norwood Procedure for Hypoplastic Left Heart Syndrome (HLHS)

The Norwood procedure is the first stage of a three-stage surgical palliation for hypoplastic left heart syndrome (HLHS), a fatal condition that would result in 90% mortality within the first month of life without intervention. 1

Overview and Purpose

The Norwood procedure, first described in 1981, is designed to achieve four critical objectives:

  • Provide an unobstructed systemic outflow tract 1
  • Create an unrestrictive inter-atrial communication 1
  • Establish a controlled source of pulmonary blood flow 1
  • Ensure a reliable source of coronary blood flow 1

Surgical Technique

The traditional Norwood procedure consists of several key components:

  • Anastomosis of the main pulmonary artery to the hypoplastic aorta to create a neo-aorta 1
  • Creation of a systemic-to-pulmonary artery shunt (modified Blalock-Taussig shunt) or a right ventricle-to-pulmonary artery conduit (Sano modification) 1
  • Atrial septectomy to ensure unrestricted blood flow between the atria 1
  • Reconstruction of the aortic arch to provide unobstructed systemic blood flow 1

Sano Modification

The Sano modification of the Norwood procedure, described in 2000, uses a right ventricle-to-pulmonary artery conduit instead of the traditional systemic-to-pulmonary artery shunt. This modification aims to improve hemodynamic stability by eliminating the diastolic "steal" phenomenon that can occur with the traditional shunt. 1

Outcomes and Survival

  • Overall survival after the Norwood procedure has improved significantly over time but appears to have plateaued in recent years 2
  • Historical in-hospital mortality decreased from 40.4% in the 1980s to approximately 15.7% in recent years 2
  • Risk factors for mortality include:
    • Anomalous pulmonary venous drainage 2
    • Moderate to severe atrioventricular valve regurgitation 2
    • Lower birth weight and gestational age 2
    • Genetic anomalies 2
    • Prolonged cardiopulmonary bypass time 3

Staged Palliation Approach

The Norwood procedure is the first stage in a three-stage approach:

  1. Stage I (Norwood): Performed in the neonatal period to establish systemic outflow and controlled pulmonary blood flow 1
  2. Stage II (Bidirectional Glenn/Hemi-Fontan): Performed at 3-6 months of age to direct superior vena cava blood directly to the pulmonary arteries 1
  3. Stage III (Fontan completion): Performed at 2-5 years of age to direct inferior vena cava blood to the pulmonary circulation, completing the separation of systemic and pulmonary circulations 1

Hybrid Alternative Approach

A hybrid approach has emerged as an alternative to the traditional Norwood procedure, particularly for high-risk patients:

  • Combines surgical and interventional catheterization techniques 1
  • Consists of:
    • Surgical placement of bilateral pulmonary artery bands 1
    • PDA stent implantation 1
    • Creation of an unrestrictive atrial communication 1
  • Performed without cardiopulmonary bypass 1
  • May be particularly beneficial for:
    • High-risk surgical candidates 1
    • Patients with ventricular dysfunction 4
    • Patients with multisystem organ failure 4
    • As a bridge to heart transplantation 1

Complications and Risks

  • Potential complications of the Norwood procedure include:

    • Coronary insufficiency 1
    • Shunt thrombosis or stenosis 1
    • Pulmonary overcirculation or undercirculation 1
    • Ventricular dysfunction 4
    • Atrioventricular valve regurgitation 2
  • Complications specific to the hybrid approach include:

    • Stent embolization 1
    • Retrograde coarctation 1
    • Proximal stenosis of uncovered ductus 1
    • Pulmonary artery distortion from banding 1

Long-term Considerations

  • Neurodevelopmental outcomes remain a concern, with multiple studies showing abnormal IQ and neurodevelopmental testing after the Norwood procedure 1
  • Regular follow-up with imaging (echocardiography, cardiac MRI) is essential to monitor ventricular function and detect potential complications 1
  • Cardiac catheterization may be needed to assess hemodynamics and pulmonary vascular resistance during the staged palliation process 5

Contraindications for Hybrid Approach

  • Significant retrograde aortic arch obstruction with a fully open PDA is a contraindication to the hybrid approach due to potential acute obstruction to coronary flow 1, 4

The Norwood procedure represents a milestone in congenital cardiac surgery, transforming HLHS from a uniformly fatal condition to one with a reasonable chance of survival through childhood 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Thirty years and 1663 consecutive Norwood procedures: Has survival plateaued?

The Journal of thoracic and cardiovascular surgery, 2019

Guideline

Management of Pediatric Patients with HLHS and SVAD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cardiac Catheterization in Hypoplastic Left Heart Syndrome (HLHS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.